A Comparison of Continuous Moderate Training and Reduced High Intensity Interval Training in Obese Young Adults
NCT ID: NCT04209647
Last Updated: 2020-07-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
24 participants
INTERVENTIONAL
2018-05-01
2019-08-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Two Different Intensity Exercises on Young Women With Obesity
NCT06610955
Exercise Training and Fitness in Severe Obesity
NCT02254200
Microvascular and Metabolic Effects of High-intensity Interval Exercise Training
NCT03236285
Investigation of the Effects of High-Intensity Interval Exercise and Moderate-Intensity Continuous Exercise on Limb Volume, Functional Capacity, and Quality of Life in Patients With Lipedema
NCT07319611
High-Intensity Interval Training and Intermittent Fasting on Body Composition and Physical Performance in Active Women
NCT04404413
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Continuous Exercise
At %60 of maximal heart rate, 30-60 minutes exercise
Continuous Aerobic Exercise
At %50 of maximum heart rate, 30-60 minutes aerobic exercise
REHIT Exercise
At %100 of heart rate 15 seconds, after this period 15 sec recovery period for all step
REHIT Exercise
-Start with warm-up period --\> %50 of maximum work rate, 3 minutes
One Exercise Cycle consists of:
* 15 seconds exercise period: %100 of maximum work rate
* 15 seconds recovery period: %50 of maximum work rate
Total Duration: 10 minutes
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
REHIT Exercise
-Start with warm-up period --\> %50 of maximum work rate, 3 minutes
One Exercise Cycle consists of:
* 15 seconds exercise period: %100 of maximum work rate
* 15 seconds recovery period: %50 of maximum work rate
Total Duration: 10 minutes
Continuous Aerobic Exercise
At %50 of maximum heart rate, 30-60 minutes aerobic exercise
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI ≥ 30,
* Female gender,
Exclusion Criteria
* Having any metabolic disease except obesity,
18 Years
22 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Istinye University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yasemin Çırak
Associate Proffesor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nurgul Durustkan Elbasi, PhD
Role: STUDY_CHAIR
Istinye University
Yunus Emre Tutuneken, PT
Role: STUDY_CHAIR
Istinye University
Yasemin Cirak, Ass Prof
Role: PRINCIPAL_INVESTIGATOR
Istınye U
Duygu Korkem, PhD
Role: STUDY_CHAIR
University of Health science
Beyza Karaduz, MsC
Role: STUDY_CHAIR
Hacettepe University
Ebru Calik Kutukcu, PhD
Role: STUDY_CHAIR
Hacettepe University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Istınye University
Istanbul, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0004
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.